Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors - Schmitt, Christian Johannes; Dietrich, Sascha; Ho, Anthony Dick; Witzens-Harig, Mathias (Annals of hematology, 2012)
Published online: 18 August 2011